drugset / Trial / NCT02275351
A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA)
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to characterize the safety, tolerability, and efficacy of topical SM04554 solution (0.15% and 0.25%) applied to the scalp of male subjects with Androgenetic Alopecia (AGA).
Timeline
- Start
- 2014-11
- Primary completion
- 2015-11
- Completion
- 2015-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DALOSIRVAT | Small molecule | 0.15 % | Topical |
| Subject | DALOSIRVAT | Small molecule | 0.25 % | Topical |